PCM
ZURA icon

Prelude Capital Management’s Zura Bio ZURA Stock Holding History

Prelude Capital Management’s Portfolio ZURA Stock Details ZURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-16,200
Closed -$40.5K – 1574
2024
Q4 		$40.5K Buy
+16,200
New +$57.7K ﹤0.01% 1156
2023
Q1 		– Sell
-150,000
Closed -$1.53M – 1504
2022
Q4 		$1.53M Hold
150,000
– – 0.08% 267
2022
Q3 		$1.51M Hold
150,000
– – 0.05% 299
2022
Q2 		$1.49M Hold
150,000
– – 0.04% 382
2022
Q1 		$1.49M Hold
150,000
– – 0.04% 460
2021
Q4 		$1.48M Buy
+150,000
New +$1.48M 0.04% 439

Other funds holding ZURA

VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
P
Pfizer New York $239M AUM 232.47% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return

Prelude Capital Management's ZURA Position: Q1 2025 in Review

Prelude Capital Management sold out of Zura Bio (ZURA) in Q1 2025, closing a stake of 16,200 shares — an estimated $40.5K sold.

Prelude Capital Management first reported a position in ZURA in Q4 2021 and held it in 6 quarters. The position peaked at $1.53M in Q4 2022. 74 funds tracked by Wall St. Rank hold ZURA as of Q1 2025.

  • Prelude Capital Management reported no remaining Zura Bio position as of Q1 2025 after selling out during the quarter.
  • Prelude Capital Management sold 16,200 Zura Bio shares in Q1 2025, an estimated $40.5K.
  • Prelude Capital Management first reported a position in Zura Bio in Q4 2021 and held it in 6 quarters.
  • Prelude Capital Management's Zura Bio position peaked at $1.53M in Q4 2022.
  • 74 funds tracked by Wall St. Rank held Zura Bio as of Q1 2025.

Based on Prelude Capital Management's 13F filing for Q1 2025, filed 15 May 2025.